Abstract
Early diagnosis, noninvasive detection, and staging of various diseases, remain one of the major clinical barriers to effective medical treatment and prevention of disease progression toward major clinical consequences. Molecular imaging technologies play an indispensable role in the clinical field in overcoming these major barriers. The increasing application of imaging techniques and agents in early detection of different diseases such as cancer has resulted in improved treatment response and clinical patient management. In this chapter we will first introduce criteria for the design and engineering of calcium-binding protein (CaBP) parvalbumin as a protein Gd-MRI contrast agent (ProCA) with unprecedented metal selectivity for Gd3+ over physiological metal ions. We will then discuss the further development of targeted MRI contrast agent for molecular imaging of PSMA biomarker for early detection of prostate cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tyszka JM, Fraser SE, Jacobs RE (2005) Magnetic resonance microscopy: recent advances and applications. Curr Opin Biotechnol 16(1):93–99. https://doi.org/10.1016/j.copbio.2004.11.004
Lippard SJ (2006) The inorganic side of chemical biology. Nat Chem Biol 2(10):504–507. https://doi.org/10.1038/nchembio1006-504
Lauffer RB, Vincent AC, Padmanabhan S, Villringer A, Saini S, Elmaleh DR, Brady TJ (1987) Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivatives. Magn Reson Med 4(6):582–590
Aime S, Barge A, Cabella C, Crich SG, Gianolio E (2004) Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr Pharm Biotechnol 5(6):509–518
Burai L, Scopelliti R, Toth E (2002) EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents. Chem Commun (Camb) 20:2366–2367
Geraldes CF, Sherry AD, Cacheris WP, Kuan KT, Brown RD 3rd, Koenig SH, Spiller M (1988) Number of inner-sphere water molecules in Gd3+ and Eu3+ complexes of DTPA-amide and -ester conjugates. Magn Reson Med 8(2):191–199
Caravan P (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35(6):512–523. https://doi.org/10.1039/b510982p
Weinmann HJ, Press WR, Gries H (1990) Tolerance of extracellular contrast agents for magnetic resonance imaging. Investig Radiol 25(Suppl 1):S49–S50
Opsahl LR, Uzgiris EE, Vera DR (1995) Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine. Acad Radiol 2(9):762–767
Langereis S, de Lussanet QG, van Genderen MH, Meijer EW, Beets-Tan RG, Griffioen AW, van Engelshoven JM, Backes WH (2006) Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed 19(1):133–141. https://doi.org/10.1002/nbm.1015
Bryant LH Jr, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA (1999) Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 9(2):348–352
Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF (2004) Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol 11(12):1361–1369. https://doi.org/10.1016/j.acra.2004.11.016
Lanza GM, Winter PM, Caruthers SD, Morawski AM, Schmieder AH, Crowder KC, Wickline SA (2004) Magnetic resonance molecular imaging with nanoparticles. J Nucl Cardiol 11(6):733–743
Lanza GM, Winter P, Caruthers S, Schmeider A, Crowder K, Morawski A, Zhang H, Scott MJ, Wickline SA (2004) Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Curr Pharm Biotechnol 5(6):495–507
Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6(6):1160–1164. https://doi.org/10.1021/nl060378g
Strijkers GJ, Mulder WJ, van Heeswijk RB, Frederik PM, Bomans P, Magusin PC, Nicolay K (2005) Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA 18(4):186–192. https://doi.org/10.1007/s10334-005-0111-y
Stosiek C, Garaschuk O, Holthoff K, Konnerth A (2003) In vivo two-photon calcium imaging of neuronal networks. Proc Natl Acad Sci U S A 100(12):7319–7324. https://doi.org/10.1073/pnas.1232232100
Wallingford JB, Ewald AJ, Harland RM, Fraser SE (2001) Calcium signaling during convergent extension in Xenopus. Curr Biol 11(9):652–661
Caravan P, Greenwood JM, Welch JT, Franklin SJ (2003) Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents. Chem Commun (Camb) 20:2574–2575
Kim Y, Welch JT, Lindstrom KM, Franklin SJ (2001) Chimeric HTH motifs based on EF-hands. J Biol Inorg Chem 6(2):173–181
Atanasijevic T, Shusteff M, Fam P, Jasanoff A (2006) Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc Natl Acad Sci U S A 103(40):14707–14712. https://doi.org/10.1073/pnas.0606749103
Xue S, Yang H, Qiao J, Pu F, Jiang J, Hubbard K, Hekmatyar K, Langley J, Salarian M, Long RC, Bryant RG, Hu XP, Grossniklaus HE, Liu ZR, Yang JJ (2015) Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging. Proc Natl Acad Sci U S A 112(21):6607–6612. https://doi.org/10.1073/pnas.1423021112
Pu F, Salarian M, Xue S, Qiao J, Feng J, Tan S, Patel A, Li X, Mamouni K, Hekmatyar K, Zou J, Wu D, Yang JJ (2016) Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI. Nanoscale 8(25):12668–12682. https://doi.org/10.1039/c5nr09071g
Pu F, Qiao J, Xue S, Yang H, Patel A, Wei L, Hekmatyar K, Salarian M, Grossniklaus HE, Liu ZR, Yang JJ (2015) GRPR-targeted protein contrast agents for molecular imaging of receptor expression in cancers by MRI. Sci Rep 5:16214. https://doi.org/10.1038/srep16214
Xue S, Qiao J, Jiang J, Hubbard K, White N, Wei L, Li S, Liu ZR, Yang JJ (2014) Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers. Med Res Rev 34(5):1070–1099. https://doi.org/10.1002/med.21313
Qiao J, Xue S, Pu F, White N, Jiang J, Liu ZR, Yang JJ (2014) Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents. J Biol Inorg Chem 19(2):259–270. https://doi.org/10.1007/s00775-013-1076-3
Li S, Jiang J, Zou J, Qiao J, Xue S, Wei L, Long R, Wang L, Castiblanco A, White N, Ngo J, Mao H, Liu ZR, Yang JJ (2012) PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities. J Inorg Biochem 107(1):111–118. https://doi.org/10.1016/j.jinorgbio.2011.11.004
Pu F, Xue S, Qiao J, Patel A, Yang JJ (2016) Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents. Curr Protein Pept Sci 17(6):519–533
Wang X, Kirberger M, Qiu F, Chen G, Yang JJ (2009) Towards predicting Ca2+−binding sites with different coordination numbers in proteins with atomic resolution. Proteins 75(4):787–798. https://doi.org/10.1002/prot.22285
Kirberger M, Wang X, Deng H, Yang W, Chen G, Yang JJ (2008) Statistical analysis of structural characteristics of protein Ca2+− binding sites. J Biol Inorg Chem 13(7):1169–1181. https://doi.org/10.1007/s00775-008-0402-7
Wang X, Zhao K, Kirberger M, Wong H, Chen G, Yang JJ (2010) Analysis and prediction of calcium-binding pockets from apo-protein structures exhibiting calcium-induced localized conformational changes. Protein Sci 19(6):1180–1190. https://doi.org/10.1002/pro.394
Zhou Y, Yang W, Kirberger M, Lee HW, Ayalasomayajula G, Yang JJ (2006) Prediction of EF-hand calcium-binding proteins and analysis of bacterial EF-hand proteins. Proteins 65(3):643–655. https://doi.org/10.1002/prot.21139
Dees A, Zahl A, Puchta R, Hommes NJ, Heinemann FW, Ivanovic-Burmazovic I (2007) Water exchange on seven-coordinate Mn(II) complexes with macrocyclic pentadentate ligands: insight in the mechanism of Mn(II) SOD mimetics. Inorg Chem 46(7):2459–2470. https://doi.org/10.1021/ic061852o
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260(6):3440–3450
Sudnick DR, Horrocks WD Jr (1979) Lanthanide ion probes of structure in biology. Environmentally sensitive fine structure in laser-induced terbium(III) luminescence. Biochim Biophys Acta 578(1):135–144
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99(9):2293–2352
Acknowledgments
We appreciate the critical review by Dr. Michael Kirberger and previous works by Drs. Fan Pu, Jingjuan Qiao, and Jie Jiang. This work is supported in part by grants R42 CA183376, R41CA177034, R41AA112713, EB007268, 1R01GM081749 from National Health Institute to Jenny J. Yang. This work was also supported by the Molecular Basis of Disease (MBD) Fellowship to M. Salarian and Center for Diagnostics and Therapeutics (CDT) Fellowship to O. Y. Ibhagui.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Salarian, M., Xue, S., Ibhagui, O.Y., Yang, J.J. (2019). Designing Calcium-Binding Proteins for Molecular MR Imaging. In: Heizmann, C. (eds) Calcium-Binding Proteins of the EF-Hand Superfamily. Methods in Molecular Biology, vol 1929. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9030-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9030-6_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9029-0
Online ISBN: 978-1-4939-9030-6
eBook Packages: Springer Protocols